Article · 28 Jun 2025
Review articlePublished 2015
Pharmacotherapy in the Cardiac Catheterization Laboratory
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cardiovascular pharmacology and therapeutics have been subject to an enormous amount of change and evolution during the last years in parallel with the revolutions in the field of catheterization laboratory. Advances in adjunct pharmacotherapy have been the foundation for progress in the catheterization laboratory. Indeed, pharmacotherapy remains essential in preventing potential complications during both diagnostic and interventional procedures and in optimizing the mechanical reperfusion therapy. Furthermore, the interventionalist must be prepared and able to medically manage an unparalleled range of conditions, ranging from diabetes and chronic kidney disease to complications such as hypotension, arrhythmias, and anaphylaxis which may present in the catheterization laboratory. The present review focuses on the appropriate utilization of adjunct pharmacotherapy in the catheterization laboratory with respect to their actions, prescribed usage, dosages, adverse reactions, cautions and common routes of administration.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Chiara Bernelli”

